SCHEMBL6161066

SCHEMBL6161066

CCOC(=O)c1cc2ccc(Cl)cc2[nH]c1=O

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 6/20 0.69
ALDH1A1 P00352 2/20 0.55
LMNA P02545 1/20 0.55
MAPT P10636 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
ADORA3 P0DMS8 2/20 0.54
DAO P14920 1/20 0.52
CSF1R P07333 1/20 0.50
PDE3B Q13370 1/20 0.48
PDE3A Q14432 1/20 0.48
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
TSHR P16473 1/20 0.48
ALOX12 P18054 1/20 0.48
KMT2A Q03164 1/20 0.48
HSD17B10 Q99714 1/20 0.48
NPC1 O15118 1/20 0.48
POLB P06746 1/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2312725 0.89 ALDH1A1 (0.55) ALOX15ALDH1A1LMNAMAPTL3MBTL1
SCHEMBL10330650 0.85 DAO (0.56) ALOX15ALDH1A1DAOKDM4ETSHR
SCHEMBL30237524 0.84 ALDH1A1 (0.55) ALOX15ALDH1A1LMNAMAPTL3MBTL1
SCHEMBL19512086 0.84 ALDH1A1 (0.55) ALOX15ALDH1A1LMNAMAPTL3MBTL1
SCHEMBL31345632 0.83 ALDH1A1 (0.57) ALOX15ALDH1A1LMNAMAPTL3MBTL1
SCHEMBL2309931 0.83 ALDH1A1 (0.57) ALOX15ALDH1A1LMNAMAPTL3MBTL1
SCHEMBL31423219 0.83 KDM4E (0.58) ALOX15ALDH1A1LMNAMAPTL3MBTL1
SCHEMBL31422797 0.83 ALDH1A1 (0.54) ALOX15ALDH1A1LMNAMAPTL3MBTL1
SCHEMBL1372751 0.82 ALDH1A1 (0.59) ALDH1A1LMNAMAPTL3MBTL1KDM4E
SCHEMBL30086907 0.82 ALDH1A1 (0.59) ALDH1A1LMNAMAPTL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1226119-B1 TYROSINE KINASE INHIBITORS MERCK & CO INC (US) 2005-03-16 EP disclosed
EP-1226119-A4 TYROSINE KINASE INHIBITORS MERCK & CO INC (US) 2003-04-09 EP disclosed
US-6479512-B1 TO TREAT TYROSINE KINASE-DEPENDENT DISEASES AND CONDITIONS, SUCH AS ANGIOGENESIS, CANCER, TUMOR GROWTH, ATHEROSCLEROSIS, AGE RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY, INFLAMMATORY DISEASES, ETC. MERCK & CO., INC. 2002-11-12 US disclosed
EP-1226119-A2 TYROSINE KINASE INHIBITORS MERCK & CO. INC. (US) 2002-07-31 EP disclosed
WO-2001028993-A2 TYROSINE KINASE INHIBITORS MERCK & CO. INC. (US) 2001-04-26 WO disclosed